0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Pharmacodynamic analysis of the microbiological efficacy of telithromycin in patients with community-acquired pneumonia.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Telithromycin, a ketolide antibacterial, demonstrates concentration-dependent bactericidal activity against the major pathogens causing community-acquired respiratory tract infections. The objective of this study was to explore the relationships between pharmacokinetic/pharmacodynamic predictor variables, such as area under the plasma concentration-time curve (AUC) over minimum inhibitory concentration (MIC) [AUC/MIC], maximum plasma concentration (C(max)) over MIC (C(max)/MIC) and microbiological outcome from telithromycin therapy for community-acquired pneumonia (CAP).

          Related collections

          Author and article information

          Journal
          Clin Pharmacokinet
          Clinical pharmacokinetics
          Springer Nature America, Inc
          0312-5963
          0312-5963
          2005
          : 44
          : 3
          Affiliations
          [1 ] Aventis Pharmaceuticals, Bridgewater, New Jersey, USA. jun.shi@frx.com
          Article
          4437
          10.2165/00003088-200544030-00007
          15762772
          e57590e3-7897-4a15-a03c-eb5b12f024cd
          History

          Comments

          Comment on this article